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Abstract
Latent inhibition (LI) is demonstrated when non-reinforced pre-exposure to a to-be-conditioned stimulus retards later learning. Learning is similarly
retarded in overshadowing, in this case using the relative intensity of competing cues to manipulate associability. Electrolytic/excitotoxic lesions to
shell accumbens (NAc) and systemic amphetamine both reliably abolish LI. Here a conditioned emotional response procedure was used to demonstrate
LI and overshadowing and to examine the role of dopamine (DA) within NAc. Experiment 1 showed that LI but not overshadowing was abolished by
systemic amphetamine (1.0mg/kg i.p.). In Experiment 2, 6-hydroxydopamine (6-OHDA) was used to lesion DA terminals within NAc: both shell- and
core- (plus shell-)lesioned rats showed normal LI and overshadowing. Experiment 3 compared the effects of amphetamine microinjected at shell and
core coordinates prior to conditioning: LI, but not overshadowing, was abolished by 10.0 but not 5.0mg/side amphetamine injected in core but not
shell NAc. These results suggest that the abolition of LI produced by NAc shell lesions is not readily reproduced by regionally restricted DA depletion
within NAc; core rather than shell NAc mediates amphetamine-induced abolition of LI; overshadowing is modulated by different neural substrates.
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Introduction
Past experience with a stimulus in the form of pre-exposure
without consequences normally reduces the level of associa-
tive learning that the pre-exposed stimulus can support
(Lubow and Moore, 1959). In a variety of procedures, this
latent inhibition (LI) eﬀect is reliably abolished by treatment
with low-dose amphetamine in both humans (Gray et al.,
1992; Kumari et al., 1999) and rats (Crider et al., 1982;
Solomon et al., 1981; Weiner et al., 1981, 1984, 1987, 1988).
LI is similarly abolished in cases of schizophrenia (Baruch
et al., 1998; Serra et al., 2001) and after electrolytic and exci-
totoxic lesions to the shell subﬁeld of the dopaminergic struc-
ture the nucleus accumbens (NAc) (Tai et al., 1995; Weiner,
2003; Weiner et al., 1996, 1999). Abolished LI is seen as
reﬂecting ‘hyperassociability’, manifest as increased condi-
tioning to a stimulus that would normally be treated as irrel-
evant. Because aberrant processing of stimulus salience has
been hypothesized to contribute to the cognitive abnormali-
ties of schizophrenia (Bleuler, 1911; Kapur, 2003, 2004), LI
has gained widespread acceptance as a model for schizo-
phrenic attention disorder (for reviews see Gray et al., 1991,
1997, 1999; Weiner 1990, 2003; Weiner and Feldon, 1997;
Weiner and Arad, 2009).
With respect to the underlying psychological mechanisms,
LI is one of a wider set of procedures that can be used to
examine the substrates of hyperassociability. Overshadowing
procedures use the relative intensity of competing cues to
manipulate associability: normally a relatively more intense
stimulus acquires associative strength at the expense of a rel-
atively less intense stimulus. Similar to LI, when overshadow-
ing is abolished hyperassociability is manifest as conditioning
to a stimulus that would normally be of low salience (cf.
Kapur, 2003, 2004). Similar to LI, overshadowing has been
reported to be abolished by treatment with amphetamine
(Oades et al., 1987; O’Tuathaigh and Moran, 2002, 2004;
O’Tuathaigh et al., 2003) and hippocampal lesions
(Schmajuk et al., 1983). Thus, the substrates responsible for
this eﬀect could well be equivalent to those mediating LI
(Cassaday, 2010; Cassaday and Moran, 2010). However, as
yet, the neuroanatomical basis of overshadowing is unclear,
e.g., some studies have reported no eﬀect on overshadowing
of lesions to hippocampus (Garrud et al., 1984; Good and
Macphail, 1994) and NAc (Horsley et al., 2008).
In the present study, we used a conditioned emotional
response (CER) procedure to demonstrate LI and over-
shadowing with equivalent experimental parameters, varying
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LI versus overshadowing, to examine the eﬀects of three
experimental manipulations. Experiment 1 tested the eﬀects
of systemic amphetamine. Experiment 2 tested the eﬀects of
6-hydroxydopamine (6-OHDA) injected within the shell and
core NAc subregions to produce diﬀerential depletion in
medial shell and core. Experiments 3A and 3B examined the
eﬀect of amphetamine micro-injected at coordinates adapted
from the Experiment 2 lesion study.
Studies using electrolytic and neurotoxic lesions have
shown diﬀerent eﬀects of shell and core NAc lesions, with
shell disrupting LI and core or whole NAc sparing and
enhancing LI depending on parametric conditions, yielding
and not yielding LI in controls, respectively (Schiller et al.,
2006; Weiner, 2003; Weiner et al., 1996, 1999). Where there is
no LI in controls, DA depletion produced by 6-OHDA has
previously been reported to enhance LI (Joseph et al., 2000).
With the LI parameters used here, selected to demonstrate
amphetamine-induced abolition of LI and compare eﬀects
on overshadowing, the equivalent DA depletion would be
expected to spare LI. However, the DA depletions made by
Joseph et al. (2000) were centred on core NAc. The eﬀects of
varying the placement of 6-OHDA injection within NAc, to
allow some dissociation of shell and core subﬁelds, have yet to
be examined. There are also in vivo dialysis and voltammetry
studies which suggest a dissociable role of DA within shell
versus core NAc in LI: speciﬁcally stimulus pre-exposure is
associated with a reduction of DA in the shell compared with
that seen on presentation of the non pre-exposed stimulus
(Jeanblanc et al., 2002; Murphy et al., 2001). The reported
eﬀects of amphetamine injected in NAc have been inconsis-
tent. This manipulation has been reported to disrupt (Joseph
et al., 2000; Solomon and Staton, 1982) or to spare LI
(Ellenbroek et al., 1997; Killcross and Robbins, 1993).
Thus, the three experimental manipulations used in the
present study were selected with two aims: (1) to address
the role of shell and core NAc with respect to the mediation
of eﬀects on LI by comparing the eﬀects of 6-OHDA and
amphetamine injected at diﬀerent coordinates within NAc;
(2) to systematically compare the eﬀects of the same experi-
mental manipulations on overshadowing, to determine
whether the two phenomena have common neural substrates
(Cassaday and Moran, 2010; Kapur, 2003, 2004). Based on
the above literature, the predictions for the present study
are as follows: (1) the systemic amphetamine treatment
used in Experiment 1 will disrupt LI and overshadowing;
(2) 6-OHDA injected in core NAc will spare LI in
Experiment 2 (as this was conducted with parameters yielding
LI in controls; cf. Joseph et al., 2000); (3) since pre-exposure
reduces DA in the shell, DA depletion in NAc shell should
similarly spare LI (when conducted with parameters yielding
LI in controls; see Jeanblanc et al. 2002; Murphy et al. 2001);
(4) amphetamine injected in NAc core will disrupt LI.
Methods
Subjects
Experimentally naive adult male Wistar rats (Charles River,
UK) were caged in pairs on a 12h:12h light/dark cycle with
food and water ad libitum. On arrival, rats were handled for
approximately 10min per day for 1 week. Procedures were
carried out in accordance with the United Kingdom (UK)
Animals Scientiﬁc Procedures Act 1986, Project Licence
number: PPL 40/2648 (Experiment 1); and PPL 40/3163
(Experiments 2 and 3). The UK Act ensures full compliance
with the ‘Principles of laboratory animal care’ (NIH publica-
tion No. 86-23, revised 1985).
Apparatus
Six identical fully automated conditioning chambers,
housed within sound-attenuating cases containing ventilation
fans (Cambridge Cognition, Cambridge, UK), were used in
Experiments 1–3. Each of the inner conditioning chambers
consisted of a plain steel box (25cm325cm322cm high)
with a Plexiglas door (19cm327cm) at the front. The ﬂoor
was a shock grid with steel bars 1cm apart and 1cm above
the lip of a 7cm deep sawdust tray. Mounted in one wall were
three stimulus lights and a waterspout. The spout was 5cm
above the ﬂoor and connected to a lickometer supplied by a
pump. Licks were registered by breaking the photo beam
within the spout, which also triggered water delivery of
0.05mL per lick. The waterspout was illuminated when
water was available. A loudspeaker for the presentation of
auditory stimuli was set in the roof. A 5s ﬂashing light, pro-
vided by the three wall-mounted stimulus lights and the house
light ﬂashing both on (0.5s) and oﬀ (0.5s) served as the con-
ditioned stimulus (CS) for control and pre-exposed animals
(there was no other background illumination). In the over-
shadowing condition, the 5s light CS was presented in com-
pound with a 5s mixed frequency noise set at 85dB (including
background noise from the fans). Scrambled footshock of 1s
duration and 1mA intensity provided the unconditioned stim-
ulus (UCS). This was delivered through the grid ﬂoor by a
constant current shock generator (pulsed voltage: output
square wave 10ms on, 80ms oﬀ, 370V peak under no load
conditions;MISACSystems,Newbury,UK).Stimuluscontrol
and data collection was by an Acorn Archimedes RISC com-
puter programmed in Basic with additional interfacing using
an Arachnid extension (Cambridge Cognition).
Procedure
Water deprivation was introduced 1day prior to shaping.
Thereafter, the animals received 1h and 15min of ad libitum
access to water in their home cage in addition to water in the
experimental chambers. The stages of the conditioned emo-
tional response (CER) procedure used in Experiments 1–3
were as follows.
Pre-training. Ratswereshapedfor1dayuntilalldrankfrom
thewaterspoutandindividuallyassignedtoaconditioningbox
for the duration of the experiment. Rats subsequently drank in
theexperimentalchamberfor15mineachday(timedfromﬁrst
lick). The drinking spout was illuminated throughout, but no
other stimuli were presented in this phase. Latency to ﬁrst lick
was measured to determine readiness to drink in the experi-
mental context. The 10 days pre-training used in Experiment 1
1650 Journal of Psychopharmacology 25(12)were subsequently shortened to 5 days in Experiments 2 and 3
for the time-limited surgical studies.
Pre-exposure. Animals were placed in the chambers where
the pre-exposed animals received 30 5s ﬂashing light CS pre-
sentations with an average inter-stimulus interval of 60s. The
control and overshadowing animals were conﬁned to the
chambers for an identical period of time without receiving
the light CS presentations. Water was not available within
the chamber and the waterspout was not illuminated during
the pre-exposure session.
Conditioning. Conditioning was conducted on the day
following pre-exposure. No water was available within the
chamber and the waterspout was not illuminated. There
were two conditioning trials in which the UCS footshock
was delivered following termination of the CS. The ﬁrst pair-
ing of CS and UCS was presented after 5min had elapsed,
and the second pairing was 5min after the ﬁrst, followed by a
further 5min left in the apparatus. For the non-pre-exposed
and pre-exposed animals the ﬂashing light served as the CS.
In the overshadowing condition, the light CS was presented in
compound with the salient noise stimulus. In the absence of
drinking, there were no behavioural measures to record.
Reshaping. On the day following conditioning, animals
were reshaped following the same procedure as in pre-training
sessions. This was in order to re-establish drinking after con-
ditioning. Reshaping also provided measures of conditioning
to the box context (latency to ﬁrst lick).
Light test. On the day following reshape, the animals were
placed in the conditioning chambers and underwent an
extinction test to the light CS. Water was available through-
out the test and the waterspout was illuminated. Once the
animals had made 50 licks, the light CS was presented for
15min. Excluding the time to ﬁrst lick, the latency to make
50 licks in the absence of the CS (the A period) provided a
measure of any individual variation in baseline lick respond-
ing. This was compared with the time taken to complete
50 licks following CS onset (B period) in a suppression
ratio (A/(AþB)) to assess the level of conditioning to the
light CS, adjusted for any individual variation in drink rate.
Noise test. On the day following the light test, the level of
conditioning to the overshadowing CS in the overshadowing
group was assessed in an extinction test, conducted in exactly
the same manner except that the noise CS was presented. The
non-pre-exposed group served as the control group in the
noise test.
Experiment 1: Systemic amphetamine administration
Drug administration. Seventy-one rats (mean weight of
221g, in the range 187–244g) were allocated to be treated
with systemic amphetamine (n¼36) or vehicle (n¼35),
administered (i.p.) 15min prior to the pre-exposure and
conditioning stages of LI. D-amphetamine sulphate (Sigma,
Poole, UK) was dissolved in physiological saline to an injec-
tion volume of 1.0mL/kg. The 1.0mg/kg dose was calcu-
lated as the salt. Control animals received an equivalent
volume of saline. The reshape and test sessions were con-
ducted drug-free.
Experiment 2: Shell and core 6-OHDA lesions
Surgical procedures. One hundred and eight rats (mean
weight 211g, in the range 180–277g) underwent surgery, for
two replications of the tests of LI and overshadowing.
In total, 36 rats were injected with 6-OHDA at shell coordi-
nates and 36 rats were injected at core coordinates, 36 rats
received sham lesions (18 were vehicle-injected at the core
coordinates and 18 were vehicle-injected at the shell coordi-
nates). Neurochemical assay was the ﬁnal arbiter of lesion
group (as described in the following). One core-injected rat
from the second replication died postoperatively.
In order to protect noradrenergic terminals, animals
received subcutaneous administration of the noradrenalin
(NA) reuptake inhibitor desipramine (20.0mg/kg) 40min
prior to surgery. Anaesthesia was induced by isoﬂurane (4%)
in a N2O/O2 (1:2, v/v) mixture and maintained thereafter with
isoﬂurane (1–2%). Stereotaxic surgery was conducted with the
incisor bar set at  3.3mm below the intra-aural line. A crani-
otomy was performed with a 1mm hand drill (to make a hole
of approximate diameter 1mm) and the dura was cut to expose
the cortex. In Experiment 2, rats received bilateral infusions of
6-OHDA or vehicle into either NAcc core or medial shell at the
following stereotaxic coordinates from bregma: core at
APþ1.6mm, ML61.8mm, DV  6.8mm; medial shell at
APþ1.3mm, ML60.8mm, DV  6.4mm and 7.0mm; one
infusion at each DV coordinate (Paxinos and Watson, 2005).
DV coordinates were taken from dura. Infusions were made via
a 31 gauge stainless steel injector attached by polythene tubing
to a 1mL Hamilton syringe. 6-OHDA hydrobromide (24.0mg/
mL as salt dissolved in vehicle; Sigma, UK) or vehicle (0.9%
saline/ascorbic acid 0.01% w/v) was infused manually over
2min on each side in a volume of 0.5mL( c o r e )o ra st w o
infusions of 0.25mL (medial shell). The injectors were left
in situ for 5min to allow absorption of the bolus and to
minimize spread of the toxin. Control animals were injected
with the vehicle at shell or core coordinates and otherwise trea-
ted identically. Rimadyl (0.03mL s.c.) provided post-operative
analgesia. Animals were allowed a 5–10day recovery before the
commencement of behavioural testing (the recovery period
varied somewhat as the lesions were conducted over 5 days).
Neurochemical assay. Following the completion of beha-
vioural testing, rats were humanely killed by dislocation of
the neck and decapitated. The brains were removed rapidly
and dissected on a cold tray. A 2mm coronal slice of brain
containing the ventral and dorsal striatum and a separate
2mm slice containing the medial prefrontal cortex were
made using a chilled brain matrix (Harvard Instruments,
USA). The brain samples were then immediately frozen on
dry ice and stored at  808C. Subsequently, a 0.84mm diam-
eter stainless steel micropunch was used to remove samples of
Nelson et al. 1651tissue from the following (left and right) brain regions: core
NAc, medial shell NAc, and infralimbic cortex. A 1.6mm
diameter stainless steel micropunch was used to remove
sample tissue from the caudate putamen and prelimbic
cortex (Figure 1). Tissue punch samples were stored in
1.5mL Eppendorf tubes and frozen at  808C.
Neurotransmitter levels in the samples were determined by
high-pressure liquid chromatography (HPLC) with electro-
chemical detection. The tissue samples were homogenized in
0.1M PCA solution by sonication and centrifuged at 17,400g
for 20min at 48C. The supernatant was injected onto the
HPLC system. The mobile phase consisted of 50mM citric
acid, 0.1mM EDTA, 8mM KCl, 50mM phosphoric acid,
100mg/L octanesulfonic acid, and 6% methanol, pH adjusted
to 3.85 by the addition of sodium hydroxide. The mobile
phase was pumped at a ﬂow rate of 0.2mL/min by an
Alexys LC100 pump connected via an Alexys AS100 auto-
sampler to an Antec Leyden reverse phase analytical column
(ALF-215 150mm32.1mm i.d.) maintained at 358C.
Neurotransmitter levels were detected using a glassy carbon
ﬂow cell (VT-03 Antec) with an ISAAC reference electrode.
An external standard consisting of DA, NA, serotonin
(5-HT), and metabolites in concentrations of 10
 7,
0.5310
 7 and 10
 8 M was injected at a volume of 4.0mL
for calibration. Samples were injected onto the column at
4.0mL volumes, except for prelimbic and infralimbic samples
which were injected at 8.0mL due to the lower DA levels.
Results were analysed using Alexys software data system.
Bradford assay was used to adjust for protein content using
the pellet remaining after sample centrifugation.
Experiments 3A and 3B: Intra-NAc
amphetamine infusions
Surgical procedures. Experiment 3A was conducted with a
total of 104 rats and Experiment 3B with a total of 112 rats
(mean weight 252g, in the range 199–289g). Both were run in
two replications in which half the rats were surgically pre-
pared for micro-injection in NAc core and the other half in
NAc shell. To this end, rats underwent the same surgical pro-
cedure as in Experiment 2 except that bilateral stainless steel
guide cannulae (22 gauge, length 11mm below guide; Plastic
One, Roanoke, VA, USA) were implanted to allow subse-
quent micro-injection (as described in the following) and
aimed at the NAc: core at APþ1.6mm, ML61.9mm, DV
 4.8mm; shell at APþ1.3mm, ML60.75mm, DV  4.7mm.
Cannulae were held in place by dental cement and anchored
to the skull with four ﬁxing screws located on diﬀerent bone
plates. Removable obturators were inserted into the guide
cannulae to prevent the cannulae from blocking.
Drug administration. In line with previous work
(Joseph et al., 2000), a single sensitizing systemic injection
of D-amphetamine sulphate (Sigma, Poole, UK) was admin-
istered (i.p.) 15min prior to the pre-exposure stage.
In Experiment 3A a dose of 1.0mg/kg was used and in
Experiment 3B a higher dose of 2.0mg/kg was used.
Control animals received an equivalent volume of saline.
The amphetamine micro-injections were administered
prior to the conditioning stage. D-amphetamine sulphate
(Sigma, Poole, UK) was dissolved in saline. In Experiment
3A a dose of 5.0mg/side was used and in Experiment 3B this
was increased to 10.0mg/side (both doses expressed as the
salt). Rats were lightly restrained, the dust caps and obtura-
tors were removed, and 31 gauge stainless steel infusion can-
nulae that protruded 2mm beyond the tip of the guide
cannulae were inserted into either the core or shell of the
NAc. The infusion cannulae were connected to two 5mL
syringes mounted on an infusion pump. A volume of 0.5mL
per hemisphere was infused over 1min and the infusion can-
nulae were left in situ for a further 1min to allow absorption
of the bolus. The infusion cannulae were then removed and
the obturators and dust caps replaced. The animals were
returned to the home cage before the onset of conditioning,
10min after completion of the micro-injection. Control ani-
mals underwent the identical procedure but received infusions
of saline.
Histological procedures. Following the completion of
behavioural testing, rats received a lethal dose of sodium pen-
tobarbitone. To aid veriﬁcation of the placement of the can-
nulae tips, infusion cannulae were inserted and 0.5mL
Pontamine sky blue dye was infused following the microinfu-
sion procedure described above. Thereafter the animals were
decapitated with a guillotine. The headcaps and guide cannu-
lae were removed and the brain taken out and ﬁxed in formal
saline for at least 7 days. Slices (80mm thick) were made using
a vibratome and were mounted onto gelatine-coated slides.
+3.00mm +1.00mm
CPu
NAc
Core
PL
IL
NAc
Shell
0.84mm
1.6mm
Figure 1. Forebrain regions dissected for postmortem neurochemical
analysis. Regions of interest were dissected by pushing micropunch
needles of 0.84 or 1.6mm diameter into the posterior face of the coronal
slices as indicated. (Adapted from Paxinos G and Watson C (1998) The Rat
Brain in Streretaxic Coordinates, 5th edition with permission from
Elsevier). Numbers indicate distance from bregma in millimetres.
1652 Journal of Psychopharmacology 25(12)Placement of the infusion cannulae tips was veriﬁed with a
light microscope and the atlas of Paxinos and Watson (2005).
Design and analysis
Statistical analysis was performed using analysis of variance
(ANOVA) with alpha set at p<0.05 for the rejection of the
null hypothesis. Signiﬁcant interactions were explored by
simple eﬀects analysis with further planned comparisons by
t-test, where appropriate. Where necessary, raw latency data
(time to ﬁrst lick at pre-training and reshape) were log trans-
formed so that their distribution was suitable for parametric
analysis.
For the light tests, the between-subject factors were con-
ditioning group (control, pre-exposed, overshadowed) and
treatment. For the noise tests, the between-subject factors
were conditioning group (control, overshadowing) and treat-
ment. In Experiment 1, the treatment was drug (saline,
amphetamine). In Experiment 2, the treatment was lesion
(vehicle, core, shell). In Experiments 3A and 3B, the treat-
ment was infusion (saline, amphetamine-core, amphetamine-
shell). Replication was initially a factor in all analyses but was
subsequently removed where there were no interactions with
conditioning group or treatment.
Results
Experiment 1: Systemic amphetamine administration
Pre-training. ANOVA of the latency to ﬁrst lick over the
10 days of pre-training showed no overall eﬀect of drug
(F(1,65)¼1.75, p¼0.191) or conditioning group-to-be
(F<1), or any interaction between these factors (F<1).
Reshape. ANOVA of latency to ﬁrst lick yielded a main
eﬀect of conditioning group (F(1,65)¼3.145, p<0.05). This
arose because the overshadowed group showed shorter laten-
cies to complete the ﬁrst lick compared to the pre-exposed
group (t(46)¼2.5, p<0.05) and marginally longer latencies
compared with the behavioural control group: mean log s
(6SEM) control group¼1.253 (60.15), pre-exposed group-
¼1.329 (60.12) and overshadowed group¼0.888 (60.13).
However, latency to drink was unaﬀected by drug, as there
was no eﬀect of drug, nor any drug by conditioning group
interaction (both F<1).
Light test. ANOVA of the suppression ratios yielded an
eﬀect of conditioning group (F(2,65)¼14.47, p<0.001).
However, as is clear from Figure 2A, the eﬀects of condition-
ing were not equivalent across the drug groups. There was a
trend towards higher levels of conditioning in the ampheta-
mine-treated animals (F(1,65)¼3.51, p¼0.066) and a condi-
tioning group3drug interaction (F(2,65)¼5.47, p<0.01).
Simple eﬀects analysis of this interaction conﬁrmed that
amphetamine treatment was without eﬀect in the control
(F<1) and overshadowed (F(1,65)¼1.1, p¼0.304) groups.
However, amphetamine clearly reduced LI in that pre-
exposed rats showed marked suppression to the light com-
pared with their saline-treated counterparts (F(1,65)¼12.94,
p<0.001). Thus, with the experimental parameters adopted
for the current study, amphetamine disrupted LI but was
without eﬀect on conditioning to the overshadowed light.
Noise test. All animals conditioned with the compound
noise–light stimulus suppressed lick behaviour following
onset of the noise stimulus and the unconditioned suppression
to the noise measured in the behavioural control groups was
unaﬀected by drug treatment (Figure 2B). ANOVA yielded
an eﬀect of conditioning group (F(1,43)¼57.88, p<0.001), but
neither an eﬀect of drug nor an interaction (both F<1).
Experiment 2: Shell and core 6-OHDA lesions
Neurochemical assay. Quantiﬁcation of the selectivity of
the Experiment 2 lesions by HPLC revealed that 11 out of
the 71 6-OHDA-injected animals showed little evidence of
Light test
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Figure 2. (A) Mean suppression ratio (6SEM) to the light for control (white bars), pre-exposed (light grey bars) and overshadowing (dark grey bars)
groups following treatment with saline or 1.0mg/kg amphetamine. (B) Mean suppression ratio (6SEM) to the noise for control (white bars) and
overshadowing (dark grey bars) groups following treatment with saline or 1.0mg/kg amphetamine.
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quently these animals were removed from the study.
In total 12 further animals were assigned to their lesion
group on the basis of the selectivity of the depletion produced
rather than the injection coordinates. The criterion for assign-
ment on the basis of the assay was less than 25% depletion in
the intended core/shell region, coupled with relatively greater
depletion in the adjacent shell/core region. On this basis, there
were 35 animals in the shell group, 25 in the core group and
36 shams.
Table 1 shows the levels (pmol/mg brain tissue corrected
for protein content) of DA, NA, and 5-HT in the ﬁve brain
regions from which samples were taken as (A) absolute levels
and (B) as the percentage depletion relative to sham levels.
These results conﬁrm that DA depletions in the shell group
were selective to the medial shell NAc ( 69%) and in this
group there were no signiﬁcant changes in DA levels in the
core. Rats in the core group showed a statistically signiﬁcant
reduction in DA levels compared with vehicle-infused con-
trols in both the core NAc ( 61%) and in the medial shell
NAc ( 65%). Signiﬁcant DA depletions were also found in
both the prelimbic and infralimbic cortices, but not the cau-
date putamen. Desipramine pre-treatment successfully
protected NA terminals in both subregions of NAc. There
was some signiﬁcant reduction in baseline NA levels in
prelimbic cortex, but this change was unlikely to have been
a direct eﬀect of 6-OHDA injection in NAc. No signiﬁcant
changes in 5-HT were detected.
Pre-training. ANOVA of the latency to ﬁrst lick over the
5 days of pre-training showed no diﬀerences by conditioning
group or lesion (maximum F(8,348)¼1.41, p¼0.19).
Reshape. Table 2 displays the mean log (10) times (s) to
complete the ﬁrst lick in the reshape session following condi-
tioning. The data show that the animals diﬀered in the level of
suppression seen to the box context with the longest latencies
in the sham-lesioned control group compared with other
lesion and conditioning groups. This observation was con-
ﬁrmed statistically as there was an interaction between con-
ditioning group and lesion (F(4,78)¼2.83, p<0.05) but no
main eﬀect of conditioning group or lesion (maximum
F(2,78)¼1.22, p¼0.31). The interaction arose because there
was an eﬀect of conditioning group in the sham-lesioned
Table 1. (A) Levels of dopamine, noradrenalin and serotonin (pmoles per mg of protein content) of sham-, core- and shell-lesioned animals in core,
shell, caudate putamen (CPu), prelimbic (PL) and infralimbic cortices (IL). (B) Percentage difference in dopamine, noradrenalin and serotonin levels of
core- and shell-lesioned animals compared with vehicle-infused sham animals in the five brain regions assayed. *p<0.05, t-test
(A)
Dopamine Noradrenalin Serotonin
Sham Core lesion Shell lesion Sham Core lesion Shell lesion Sham Core lesion Shell lesion
Core sample 4.652
(60.391)
1.817
(60.201)
4.563
(60.401)
0.266
(60.046)
0.273
(60.098)
0.233
(60.04)
0.289
(60.018)
0.29
(60.032)
0.301
(60.058)
Shell sample 5.147
(60.488)
2.088
(60.476)
2.034
(0.199)
0.833
(60.141)
0.841
(60.203)
0.832
(60.212)
0.5
(60.051)
0.403
(60.052)
0.464
(60.051)
CPu sample 7.873
(60.371)
7.271
(60.438)
7.87
(60.258)
0.165
(60.009)
0.147
(60.008)
0.151
(60.006)
0.242
(60.016)
0.218
(60.01)
0.244
(60.015)
PL sample 0.58
(60.003)
0.25
(60.003)
0.35
(60.005)
0.21
(60.01)
0.163
(60.013)
0.143
(60.011)
0.17
(60.009)
0.159
(60.012)
0.168
(60.008)
IL sample 0.122
(60.057)
0.045
(60.007)
0.056
(60.019)
0.379
(60.099)
0.237
(60.042)
0.196
(60.038)
0.221
(60.022)
0.185
(60.026)
0.222
(60.19)
(B)
Dopamine Noradrenalin Serotonin
Core lesion Shell lesion Core lesion Shell lesion Core lesion Shell lesion
Core sample  64.7%*
(63.7)
 1.2%
(611.1)
 13.5%
(623.2)
 13.6%
(612.4)
 4.4%
(610.1)
þ1.2%
(614.4)
Shell sample  65.4%*
(67.4)
 69.6%*
(63.2)
 13.6%
(614.7)
 16.4%
(610.5)
 18.5%
(66.4)
 1.4%
(68.1)
CPu sample þ1.7
(65.1)
þ2.9%
(64.3)
 10.7%
(65.8)
þ0.3%
(65.6)
 3.8%
(64.9)
þ4.5%
(64.6)
PL sample  51.7%*
(65.7)
 41.2%*
(69.1)
 14.9%*
(65.9)
 30.1%*
(65.1)
 1.6%
(69.1)
þ1.6%
(64.7)
IL sample  34.9%*
(69.1)
 54.9%*
(66.2)
 19.4%
(69.8)
 32.7%*
(67.4)
 9.1%
(610.1)
 8.2%
(66.9)
1654 Journal of Psychopharmacology 25(12)rats (F(2,87)¼3.76, p<0.05), with shorter latencies in the pre-
exposed (t(20)¼3.1, p<0.01) and overshadowed groups
(t(19)¼3.5, p<0.01) compared with the controls (p<0.05).
However, there were no diﬀerences in latency to ﬁrst lick
between the three conditioning groups in either the core- or
shell-injected rats (maximum F(2,87)¼1.94, p¼0.15).
Light test. The mean suppression ratios to the light CS are
presented in Figure 3A. This shows that both LI and over-
shadowing were unaﬀected by lesion as all of the pre-exposed
and overshadowed groups showed less conditioning to the
light CS than the control animals, irrespective of lesion.
This description of the data was supported statistically as
ANOVA yielded an eﬀect of conditioning group (F(2,87)¼
15.28, p<0.001) but neither an eﬀect of lesion nor an inter-
action (maximum F(2,87)¼1.1, p¼0.34).
Noise test. The mean suppression ratios to the noise CS are
presented in Figure 3B. All animals that were conditioned
with the compound (lightþnoise) CS showed marked sup-
pression to the noise CS irrespective of lesion. As expected,
the control animals showed little unconditioned suppression
to the noise CS. ANOVA yielded an eﬀect of conditioning
group (F(1,68)¼150.1, p<0.001) and a marginal eﬀect of
lesion (F(2,61)¼3.14, p¼0.051) but no interaction (F<1).
However, no further comparisons of the eﬀect of lesion
were statistically reliable. This means that the main eﬀect of
lesion arises because of overall increased suppression, without
signiﬁcant distinction between the eﬀects of shell and core
placements on conditioned and unconditioned suppression.
More stringent inclusion criterion. The above eﬀects of
lesion on reshape latencies and tone suppression provide a
positive control in that the lesions were not simply ineﬀective,
depleting DA insuﬃciently to have any behavioural eﬀects.
However, it remains possible that the lack of eﬀect of the
lesion on LI and overshadowing could potentially be because
the 6-OHDA infusions did not produce suﬃcient DA cell
loss. We therefore applied a more stringent inclusion criterion
(i.e. minimum DA depletion of 50% in target region) and
reanalysed the data accordingly. However, the reanalysis
did not change the original conclusion that the lesions were
without eﬀect on either LI or overshadowing under the pre-
sent experimental conditions. ANOVA again revealed no
eﬀect of lesion or conditioning group3lesion interaction
(both F<1).
Experiments 3A and 3B: Intra-NAc
amphetamine infusions
Histological verification. In Experiment 3A, 8 animals
were excluded on the basis of histological veriﬁcation leaving
47 core-implanted (30 infused with amphetamine and 17 with
saline) and 49 shell-implanted animals (33 infused with
amphetamine and 16 with saline). In Experiment 3B, 6 ani-
mals were excluded on the basis of histological veriﬁcation
leaving 56 core-implanted (37 infused with amphetamine and
19 with saline) and 50 shell-implanted animals (33 infused
with amphetamine and 17 with saline).
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Figure 3. (A) Mean suppression ratio (6SEM) to the light for control (white bars), pre-exposed (light grey bars) and overshadowing (dark grey bars)
groups following sham or 6-hydroxydopamine lesions to either the core or shell subregions of the nucleus accumbens. (B) Mean suppression ratio
(6SEM) to the noise for control (white bars) and overshadowing (dark grey bars) groups following sham or 6-hydroxydopamine lesions to either the
core or shell subregions of the nucleus accumbens.
Table 2. Mean latency (log s) to complete the first lick on the reshape
session for control, pre-exposed and overshadowed groups following
sham or 6-hydroxydopamine lesions to either the core or shell subregions
of the nucleus accumbens
Control Pre-exposed Overshadowed
Sham 1.88 (60.22) 1.30 (60.17) 1.14 (60.18)
Core 1.36 (60.22) 0.94 (60.29) 1.51 (60.14)
Shell 1.21 (60.18) 1.41 (60.23) 1.35 (60.16)
Nelson et al. 1655Figure 4 shows schematic reconstructions of infusion sites
within the NAc core and NAc shell for amphetamine- and
saline-infused animals. There was a clear anatomical dissoci-
ation in the location of the infusion sites between the medial
shell and the core of the NAc.
Pre-training. In Experiment 3A, ANOVA of the latency to
ﬁrst lick over the 5 days of pre-training showed no diﬀerences
by conditioning group or infusion (maximum F(2,87)¼2.3,
p¼0.11). Similarly, in Experiment 3B, there were no diﬀer-
ences by conditioning group or infusion (maximum
F(2,96)¼1.4, p¼0.25).
Reshape. In neither experiment was there any evidence that
the level of conditioning to the experimental chamber mea-
sured as latency to lick in the reshape sessions was aﬀected by
conditioning group or infusion (maximum F(2,87)¼2.02,
p¼0.14).
Light test. Figure 5A suggests that the groups diﬀered by
conditioning and infusion group in that the overshadowing
eﬀect appeared to be attenuated by infusions of 5mg/side.
However, this apparent reduction in overshadowing was not
supported statistically. Analysis of the suppression ratio to
the light CS revealed an eﬀect of conditioning group
(F(2,87)¼18.82, p<0.001) but no eﬀect of infusion (F<1)
nor an interaction (F(4,87)¼1.72, p¼0.15).
In Experiment 3B, there was no eﬀect of conditioning
group or infusion on the A periods (maximum F(2,97)¼1.68,
p¼0.19), conﬁrming that the groups were again well matched
for drinking prior to the critical suppression test. Figure 6A
shows that there was no eﬀect of amphetamine infusions into
the shell on either LI or overshadowing at 10.0mg/side.
However, 10.0mg/side amphetamine infused into the core
appeared to abolish LI without aﬀecting overshadowing.
This description of the data was conﬁrmed by ANOVA
which yielded a marginal eﬀect of infusion (F(2,97)¼2.66,
p¼0.075), a clear eﬀect of conditioning group (F(2,97)¼
14.27, p<0.001) and moreover a signiﬁcant interaction
between these factors (F(4,97)¼3.74, p<0.01). Simple eﬀects
analysis of this interaction revealed no eﬀect of infusion in
either the control or overshadowed groups (both F<1), but
an eﬀect of infusion in the pre-exposed animals (F(2,97)¼9.33,
p<0.001) as the amphetamine-core LI group showed greater
conditioning to the light compared with both their saline
(t(23)¼7.5, p<0.001) and amphetamine-shell counterparts
(t(25)¼4.35, p<0.001).
Noise test. There was no evidence that either dose of
amphetamine had any eﬀect on the level of suppression to
the noise CS (maximum F(2,67)¼1.46, p¼0.24). In both
experiments (data shown in Figures 5B and 6B), over-
shadowed animals showed marked suppression to the noise
CS (minimum F(1,61)¼194.5, p<0.001).
Discussion
Experiment 1 conﬁrmed that the LI aspect of the CER proce-
dure was amphetamine-sensitive. However, despite that fact
that the reduction in learning resulting from LI and
NAc core (A) (B) NAc core NAc Shell NAc Shell
Amphetamine 5mg
Saline
Amphetamine 5mg
Saline
Amphetamine 10mg
Saline
Amphetamine 10mg
Saline
+ 2.20
+ 1.90
+ 1.70
+ 1.50
+ 1.30
1 0 2 1 0 2
+ 1.30
+ 1.50
+ 1.70
+ 1.90
+ 2.20 + 2.20 + 2.20
+ 1.90 + 1.90
+ 1.70 + 1.70
+ 1.50 + 1.50
+ 1.30 + 1.30
Figure 4. Histological assessment of cannula placements within the nucleus accumbens. Representative coronal sections from rats that received micro-
injections of 5.0mg amphetamine (A) or 10.0mg amphetamine (B) into the NAc core and NAc shell. Outlines are reproduced from Paxinos G and Watson C
(1998) The Rat Brain in Streretaxic Coordinates, 5th edition with permission from Elsevier). Coordinates refer to the distance in millimetres anterior to bregma.
1656 Journal of Psychopharmacology 25(12)overshadowing was (as in Experiments 2 and 3) near identical,
the overshadowing aspect of the procedure was amphetamine-
insensitive at the dose tested (1.0mg/kg, i.p.). In Experiment 2,
DA depletion produced by 6-OHDA in NAc was without a
detectable eﬀect on LI or overshadowing. However, at similar
coordinates, and in the equivalent volume, the Experiment 3B
amphetamine infusion in NAc core but not shell was demon-
strated to abolish LI but not overshadowing, at the 10.0 but
not the 5.0mg/side dose. Thus, the eﬀects of all three experi-
mental manipulations on LI were in line with predictions,
whilst there were no signiﬁcant eﬀects on overshadowing.
The 6-OHDA lesions
In the present study, as a ﬁrst step, the eﬀects of DA depletion
in shell and core sub-regions of NAc were tested with
experimental parameters designed to produce reliable LI in
the vehicle-injected controls, because these were the parame-
ters suitable to test for the disruption of LI predicted to result
from the amphetamine treatments (Weiner, 2003; Weiner and
Arad, 2009) and to test for any disruption in overshadowing.
That DA depletion in shell was without eﬀect on LI con-
ducted with these parameters suggests that reducing the
actions of DA within NAc does not readily reproduce the
pattern of results obtained with electrolytic and excitotoxic
lesions to shell (Tai et al., 1995; Weiner, 2003; Weiner et al.,
1996, 1999) and points to a particular role for DA within
medial shell NAc in the modulation of LI. The present results
are moreover consistent with in vivo studies of DA release in
NAc showing that the expression of LI is associated with
reduced DA release within the medial shell but not core
NAc. Speciﬁcally, it has been shown that extracellular levels
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Figure 5. (A) Mean suppression ratio (6SEM) to the light for control (white bars), pre-exposed (light grey bars) and overshadowing (dark grey bars)
groups following injection of vehicle or 5.0mg amphetamine in either the core or shell subregions of the nucleus accumbens. (B) Mean suppression
ratio (6SEM) to the noise for control (white bars), pre-exposed (light grey) and overshadowing (dark grey bars) groups following injection of vehicle or
5.0mg amphetamine in either the core or shell subregions of the nucleus accumbens.
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Figure 6. (A) Mean suppression ratio (6SEM) to the light for control (white bars), pre-exposed (light grey bars) and overshadowing (dark grey bars)
groups following injection of vehicle or 10.0mg amphetamine in either the core or shell subregions of the nucleus accumbens. (B) Mean suppression
ratio (6SEM) to the noise for control (white bars), pre-exposed (light grey) and overshadowing (dark grey bars) groups following injection of vehicle or
10.0mg amphetamine in either the core or shell subregions of the nucleus accumbens.
Nelson et al. 1657of DA are increased in the medial shell when a CS is paired
with an aversive event but that this conditioned release is
eliminated following non-reinforced pre-exposure to the CS
(Jeanblanc et al., 2002; Murphy et al., 2001). Based on these
studies, the results obtained with the 6-OHDA lesions are, at
face value, entirely as expected.
However, lesion selectivity should be considered because
complete NAc lesions that span both shell and core subre-
gions are known to spare LI (Jongen-Relo et al., 2002;
Konstandi and Kafetzopolous, 1993; Weiner et al., 1996).
The 6-OHDA lesions tested in the present study were clearly
diﬀerent according to the placement of the 6-OHDA injec-
tion. Whilst the shell lesion was successfully selective in that
the DA depletion produced did not extend to the core sample,
injection at the ‘core’ placement depleted DA in shell and
core. This pattern of anatomical selectivity of the shell but
not core lesion is consistent with other reports of the eﬀects of
6-OHDA infusions into the core and medial shell of the NAc
(e.g., Sellings and Clarke, 2003; Sellings et al., 2008;
Sokolowski and Salamone 1998) and may relate to the asym-
metric connectivity between shell and core (van Dongen et al.,
2005). In any event, the shell lesion, the site at which electro-
lytic and excitotoxic lesions abolish LI, was both neuroana-
tomically and neurochemically selective. The lack of eﬀect of
the present shell lesions could be suggested to be due to the
procedure used to diﬀerentiate shell and core in the present
study, principally by varying the laterality of injection, in
order to lesion shell without passing through overlying core
NAc. However, the ventral aspect of shell is similarly intact
in other studies which show LI abolition after shell but not
core lesions (Schiller et al., 2006; Weiner 2003; Weiner et al.,
1996, 1999).
The signiﬁcant changes in prelimbic and infralimbic
cortices could be secondary, consistent with the known inter-
connectivity of prelimbic and infralimbic regions with NAc
core and shell, respectively (Berendse et al., 1992; Gorelova
and Yang, 1997). Alternatively, these changes could be a
direct consequence of damage to dopaminergic ﬁbres en
route to prefrontal cortex, which pass near NAc. However,
there was no evidence that the low volume of neurotoxin
injected in the present study spread beyond NAc: there were
no signiﬁcant neurochemical changes dorsally in caudate
putamen.
Overall, the magnitude of the DA depletions produced by
the local injections of 6-OHDA in the present study was not
very large and this may account for their lack of eﬀect. It is
not uncommon to have 75–90% depletions of DA with local
injections of 6-OHDA (e.g., Correa et al., 2002; Cousins et al.,
1993; Salamone et al., 2001; Sokolowski and Salamone 1998).
However, the exclusion criterion adopted made no diﬀerence
to the lack of eﬀect on the learning measure and the lesions
were nonetheless behaviourally eﬀective in that they moder-
ated the level of contextual conditioning to the box cues mea-
sured at reshape. Similarly, there was some evidence that the
lesions aﬀected (conditioned and unconditioned) suppression
to the noise CS. In other tests (of novel object recognition)
these lesions showed dissociable behavioural eﬀects (Nelson
et al., 2010). Subsequently using a reduced number of pre-
exposures, LI enhancement has been demonstrated with sim-
ilar levels of DA depletion in shell (Nelson et al., 2009), and as
would be predicted on the basis of the available vivo dialysis
and voltammetry studies (Jeanblanc et al., 2002; Murphy
et al., 2001); see also the discussion above.
Amphetamine abolition of LI mediated in core
Conditioning is known to be the critical experimental stage at
which amphetamine eﬀects on LI are mediated (Joseph et al.,
2000; Weiner et al., 1988) and in the present study micro-
injection in core but not shell NAc disrupted LI at the con-
ditioning stage of the procedure. In contrast, electrolytic and
excitotoxic core lesions enhance rather than disrupt LI
(Schiller et al., 2006; Weiner 2003; Weiner et al., 1996,
1999). Thus, the current ﬁndings further suggest that amphet-
amine disrupts LI by activating the core and promoting beha-
vioural switching to the stimulus-reinforcement contingencies
acquired at conditioning. This is consistent with the switching
hypothesis of LI which posits that disrupted LI is the result of
excessive switching and that switching is subserved by a mech-
anism that resides in the NAc core and is activated by
increased DA levels in core (Weiner, 2003). Moreover, if
such excitatory eﬀects of amphetamine reﬂect a DA D1
rather than a D2 proﬁle of action (Greengard, 2001;
Traynor and Neubig, 2005), this would in turn suggest DA
D1-mediation of the abolition of LI, at least in core NAc.
Experiments 3A and 3B also show the importance of dose
of micro-infusion and sensitizing injection. Amphetamine
injected in NAc at 5.0mg/side was suﬃcient to abolish LI in
an earlier study (Joseph et al., 2000), although at a higher
injection volume of 1mL, but was without eﬀect on LI
under our experimental conditions. Experiment 3B used a
higher dose of 10.0mg/side, also standard in studies of this
kind (Ellenbroek et al., 1997; Killcross and Robbins, 1993).
However, neither of these previous studies showed abolished
LI after amphetamine injection in NAc at 10.0mg/side. Thus,
the emergence of the eﬀect on LI in Experiment 3B may in
part be attributable to the increased dose of sensitizing injec-
tion required under our experimental conditions (2.0mg/kg).
In any event, our results further underscore the importance of
such an injection (see Joseph et al., 2000): earlier studies
which failed to show any eﬀect on LI of amphetamine when
directly injected into NAc did not use a sensitizing injection
(Killcross and Robbins, 1993) and/or did not target core NAc
(Ellenbroek et al., 1997).
Why were there no effects on overshadowing?
The 1.0mg/kg D-amphetamine dose used in Experiment 1 is
equivalent to that found to abolish LI in CER procedures
(Weiner et al., 1981, 1984, 1987, 1988; Killcross et al., 1994)
and has previously been reported to abolish overshadowing in
CER procedures (O’Tuathaigh and Moran, 2002, 2004;
O’Tuathaigh et al., 2003; but see Horsley and Cassaday,
2003). The diﬀerent strains of rats used may account for
this diﬀerence between laboratories. The nonsigniﬁcant
results of Experiment 3A in which the overshadowing eﬀect
showed a tendency to be reduced after infusions of 5mg/side
suggests that eﬀects on overshadowing might be demon-
strated in lower dose ranges under our experimental condi-
tions (Figure 5A).
1658 Journal of Psychopharmacology 25(12)Conclusions
The present results suggest that lesion-induced abolition of LI
is not readily reproduced by regionally restricted DA deple-
tion within NAc and that core rather than shell NAc mediates
amphetamine-induced abolition of LI. The lack of eﬀect after
the 6-OHDA core lesion was as expected, based on all lesion
studies to date. The lack of eﬀect of the 6-OHDA shell lesion,
whilst apparently contrary to the eﬀects of excitotoxic and
electrolytic lesions, was as expected based on dialysis and
voltammetry studies.
Amphetamine treatments were without signiﬁcant eﬀect
on overshadowing in the present study, possibly in relation
to dose, and pointing to dissociation in the neuromodulatory
mechanisms for salience modulation as measured in LI and
overshadowing procedures. Further studies will be needed to
determine the contributions of the DA D1- and D2-like recep-
tor families in the abolition and enhancement of LI and
overshadowing.
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